BDSX - Biodesix to raise $11.7M through equity offering guides FY22 revenue within the consensus range

Biodesix (NASDAQ:BDSX) raised $11.7M through sale of 6,508,376 common shares on April 7, 2022 in a private placement. Net proceeds will be utilized to fund the partial repayment of its existing term loan and general corporate purposes, including our strategic growth. The Company reaffirms its previous guidance and anticipates FY22 revenue between $37.5M to $39.5M in total revenue in 2022 vs consensus of $38.55M. Concurrently, the company entered into a third amendment to its 2021 term loan on April 7, 2022, which includes certain consents and waivers to provide the company additional financial flexibility over the near term. Per the agreement the company agreed to repayment of $3M in outstanding principal in April 2022 with an additional $2M to be paid later.

For further details see:

Biodesix to raise $11.7M through equity offering, guides FY22 revenue within the consensus range